Vertebrate Antibodies Limited

Vertebrate Antibodies Ltd from Aberdeen, UK, is a small holding company with an active status, established 14 years ago. The company employs six people and holds £1,192,738 in assets, operating from a real address shared by only one other business. It’s led by three directors and owned by a single entity, and it’s an irregular importer, primarily dealing in miscellaneous chemical products, with the last import occurring two months ago in December 2024.

The company's core function is research and experimental development within the biotechnology sector. While a website isn’s available, it’s clear the company is focused on scientific endeavors.

Financially, Vertebrate Antibodies Ltd presents a mixed picture. Cash bank on hand has increased by a significant 74% to £970,000, a positive sign of liquidity. However, net current liabilities have increased by 110% to -£970,000, indicating a potential strain on short-term obligations. Creditors have also risen considerably, increasing by 87% to £2.2 million. On the plus side, debtors have increased by 140%, suggesting improved collection efforts, and corporation tax recoverable has grown by 150%. The company’s small size—meeting two of three conditions for being classified as small—allows for agility, but the increase in liabilities is something to watch. The company’s equity has decreased by 160% to -£880,000, which is a big change.

The company’s financial statements are unaudited, and the auditor is not mentioned. The company is showing a lot of growth, but it’s also burning through money. The support of the parent company, Epitogenx Ltd, will be crucial for the company’s continued operation.

Registered in Scotland under the registration number SC396954, with a registered address at AB24 2TZ, Aberdeen, C/O DR STEVE BIRD, Zoology Department Tillydrone Avenue.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.